Our portfolio of therapeutic candidates spans three main categories: ex vivo treatments for hemoglobinopathies, such as sickle cell disease and β-thalassemia, allogeneic CAR-T cell therapies for cancer, and in vivo treatments for diseases of the liver, lung, and muscle. Benefits information above is provided anonymously by current and former CRISPR Therapeutics employees, and may include a summary provided by the employer. CRISPR/Cas9 is a revolutionary technology that allows for precise, directed changes to genomic DNA. Editas Medicine is CRISPR Therapeutics's #1 competitor. Learn about CRISPR Therapeutics , including insurance benefits, retirement benefits, and vacation policy. CRISPR Therapeutics is focused on the development of transformative medicines using its proprietary CRISPR/Cas9 gene-editing platform. Glassdoor is your resource for information about CRISPR Therapeutics benefits and perks. See insights on CRISPR Therapeutics including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. Our therapeutic approach is to cure diseases at the molecular level using CRISPR/Cas9 gene editing. CRISPR Therapeutics is a biopharmaceutical company created to translate CRISPR-Cas9, a breakthrough genome-editing technology, into transformative medicines for serious human genetic diseases.The company is uniquely positioned to translate CRISPR-Cas9 technology into human therapeutics, thanks to its multi-disciplinary team of world-renowned academics, clinicians and drug developers. Editas Medicine operates in … Editas Medicine was founded in Cambridge, Massachusetts} in 2013. This is the CRISPR Therapeutics company profile. The top 10 competitors average 108. Sep 03, 2020 CRISPR Therapeutics to Present at the Wells Fargo 2020 Virtual Healthcare Conference. CRISPR Therapeutics AG total number of employees in 2019 was 304, a 61.7% increase from 2018.; CRISPR Therapeutics AG total number of employees in 2018 was 188, a 48.03% increase from 2017.; CRISPR Therapeutics AG total number of employees in 2017 was 127, a 36.56% increase from … Glassdoor gives you an inside look at what it's like to work at CRISPR Therapeutics, including salaries, reviews, office photos, and more. CRISPR Therapeutics has 304 employees across 4 locations and $289.59 M in annual revenue in FY 2019. Interactive chart of CRISPR Therapeutics AG (CRSP) annual worldwide employee count from 2015 to 2020. CRISPR Therapeutics’ mission is to develop transformative gene-based medicines that offer the possibility of curative treatments. CRISPR Therapeutics is a leading gene-editing company focused on the development of transformative medicines using its proprietary CRISPR/Cas9 gene-editing platform. CRISPR Therapeutics and Vertex Pharmaceuticals Announce Priority Medicines (PRIME) Designation Granted by the European Medicines Agency (EMA) to CTX001™ for the Treatment of Sickle Cell Disease. All content is posted anonymously by employees working at CRISPR Therapeutics. CRISPR Therapeutics has 188 employees and is ranked 3rd among it's top 10 competitors.